A2 Milk share price: why UBS sees further upside
We examine why analysts from UBS see further upside for the stock ahead of its full-year results.
When will the company report its FY20 results?
Fresh milk and infant formula dairy company a2 Milk (A2M) is set to report its full-year (FY20) results next Wednesday, 19 August.
A2 Milk share price: analysts remain bullish
Heading into a2’s full-year results release, the sell-side remains bullish on the company’s prospects, with the stock commanding and Overweight rating, on average, according to the Wall Street Journal. Though analysts may currently favour the stock, its ultimately been a volatile year for the company – with the a2 Milk share price trading between $11.28 per share and $20.05 per share over the last 52 week period.
On a more granular level, A2M currently has 5 Buy ratings, 1 Overweight rating, 2 Hold ratings, 1 Underweight Rating and 2 Sell ratings, also according to the Wall Street Journal.
Analysts from Swiss investment bank UBS – which have remained bullish on A2M for some time now – recently reiterated their Buy rating and NZ$22.00 per share price target on the stock.
Overall the investment bank said it expected the company to beat expectations at the FY20. Here, UBS analysts said:
‘Pulling together the data mosaic across A2M's sale channels and operating costs points to a potential FY20 consensus EBITDA beat of ~4% driven by stronger margins.’
For reference, in April, A2M upgraded their full-year earnings (EBITDA) margin expectations to between 31-32% – a figure which factored in a planned marketing spend of approximately NZ$200 million. UBS however expects the company’s costs to come in lower than guided as a result of Mom and Baby Stores (MBS) closures – contributing to the above highlighted earnings beat.
Looking forward, the investment bank argued that the company remains well placed to capitalise on the Chinese infant formula market, saying:
‘Our analysis suggests A2M enters FY21 with a record CBEC market share in July and MBS sales ahead of pre-COVID-19 helped by a larger store footprint.’
Overall, UBS is currently forecasting that A2M will report FY20 revenues of NZ$1,741 million, against EBIT of NZ$556.7 million and net earnings of NZ$392.5 million
Other bits and pieces
Elsewhere, a2 Milk recently announced the appointment of its new Managing Director and Chief Executive Officer: Mr David Bortolussi. Mr Bortolussi has significant senior management experience, most recently working as Group President of International Innerwear at HanseBrands.
Mr Bortolussi is set to take the reigns during the early parts of CY21.
Want to take a position in CSL, long or short?
Create an IG trading account or log in to your existing account to get started now.
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.
Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets
- Forex
- Shares
- Indices
See more forex live prices
See more shares live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
See more indices live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.